Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
BICYCLE THERAPEUTICS plc (BCYC) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 144 Form 144 - Report of proposed sale of securities:
10/03/2023 144 Form 144 - Report of proposed sale of securities:
10/03/2023 144 Form 144 - Report of proposed sale of securities:
10/03/2023 144 Form 144 - Report of proposed sale of securities:
10/03/2023 144 Form 144 - Report of proposed sale of securities:
10/03/2023 144 Form 144 - Report of proposed sale of securities:
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
Docs: "Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update"
07/19/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/13/2023 8-K Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Other Events, Financial Statements...
Docs: "Bicycle Therapeutics plc 4,705,884 American Depositary Shares representing 4,705,884 Ordinary Shares, nominal value £0.01 per share 4,705,882 Non-Voting Ordinary Shares, nominal value £0.01 per share",
"Description of the Non-Voting Ordinary Shares",
"Granta Park, Great Abington"
07/13/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/12/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
05/26/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Opinion of Cooley (UK) LLP"
05/26/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/26/2023 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
05/10/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology"
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
04/13/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/03/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Bicycle Therapeutics Enhances Leadership Team with Key Appointments"
03/28/2023 8-K Quarterly results
02/28/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
02/28/2023 10-K Annual Report for the period ended December 31, 2022
02/28/2023 8-K Quarterly results
Docs: "Bicycle Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update"
02/24/2023 SC 13G Paradigm Biocapital Advisors LP reports a 5.4% stake in Bicycle Therapeutics plc
02/14/2023 SC 13G/A Logos Global Management LP reports a 4.8% stake in Bicycle Therapeutics plc
02/14/2023 SC 13G/A Ridgeback Capital Investments L.P. reports a 7.6% stake in Bicycle Therapeutics plc
02/14/2023 SC 13G/A Ridgeback Capital Investments L.P. reports a 7.6% stake in Bicycle Therapeutics plc
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy